Trial
NCT02467582
Adjuvant Aspirin Treatment for Colon Cancer Patients
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Swiss Cancer Institute
Collaborators
European Organisation for Research and Treatment of Cancer - EORTC; Central European Society for Anticancer Drug Research
Condition
Colon Cancer
Intervention
Aspirin
Why stopped
Board decision in 2020 due to lack of financial funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-16